PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1550614
PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1550614
Global protein assays market is estimated to be valued at USD 2.50 Bn in 2024 and is expected to reach USD 5.45 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 11.8% from 2024 to 2031.
Report Coverage | Report Details | ||
---|---|---|---|
Base Year: | 2023 | Market Size in 2024: | US$ 2.50 Bn |
Historical Data for: | 2019 to 2023 | Forecast Period: | 2024 to 2031 |
Forecast Period 2024 to 2031 CAGR: | 11.80% | 2031 Value Projection: | US$ 5.45 Bn |
Protein assays are analytical techniques that are used to determine the concentration of proteins in a solution or extract. It plays a vital role in quantitative analysis of proteins and aids in discovering protein interactions. Global protein assays market growth is driven by rising demand from biopharmaceutical companies and research institutes. Widespread application of these assays in various research areas such as disease diagnosis, drug discovery, toxicity testing can drive the market growth. Advancements in assay technologies allowing high-throughput screening and reproducibility have boosted their adoption across industries. However, stringent regulatory guidelines and requirement of skilled professionals can pose challenges for the market players.
Global protein assays market growth is driven by factors like increasing R&D investments in life science research, growing biopharmaceutical industry, and rising prevalence of chronic and infectious diseases. Protein-based drugs and therapeutics have emerged as an important area of research, owing to their high selectivity and efficiency. This has tremendously boosted demand for protein analysis techniques among pharmaceutical companies. Expansion of clinical research and drug discovery activities can also drive the market growth. Furthermore, technological advancements leading to development of microfluidic-based assays, spectrometry techniques, and automation can enhance the capabilities and efficiency of these assays. However, stringent regulatory framework for approval of these assays can hamper the market growth. Moreover, high costs associated with instruments and lack of skilled professionals pose challenges for the market growth.
This report provides in-depth analysis of the global protein assays market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global protein assays market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Thermo Fisher Scientific, Merck KGaA, Bio-Rad Laboratories, Inc., PerkinElmer Inc., GE Healthcare
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global protein assays market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global protein assays market
Detailed Segmentation-